Dr Reddy's Laboratories' API plant in Telangana received two observations in a Form 483 during a recent inspection by the ...

Pharma major Dr Reddy’s Laboratories Ltd’s consolidated net profit increased 21 per cent in the fourth quarter ended March 31, 2025 at ₹1,587 crore against ₹1,307 crore in the ...

Dr Reddy’s Laboratories on Friday said its consolidated net profit increased 21 per cent year-on-year to Rs 1,587 crore during the March quarter, aided by strong sales across all regions ...

On Friday, May 9, 2025, major companies such as Swiggy, Dr Reddy's, Manappuram Finance and Bank of India are scheduled to announce financial results, according to the BSE calendar.

Amid growing concerns about potential US import tariffs on pharmaceuticals, Indian generics giant Dr. Reddy's Laboratories is taking steps to secure its supply chain for key products entering the ...

Generic drugmaker Dr. Reddy’s Laboratories is open to manufacturing in the U.S., including through acquisitions, if such a need remains, CEO Erez Israeli said on Friday. “It is a very ...

HYDERABAD, May 9 (Reuters) - India's Dr Reddy's Laboratories (REDY.NS), opens new tab, one of country's largest generic drugmakers, said that it is open to expanding its manufacturing footprint in ...

Sen. Bill Cassidy and state Sen. Thomas Pressly were among a group touring the manufacturing plant formerly owned by Dr. Reddy's, a global pharmaceutical company. Officials from the Louisiana ...

The inspection by the U.S. Food and Drug Administration (FDA) focused on the company's active pharmaceutical ingredients (API ...

Dr. Reddy’s Laboratories, a prominent pharmaceutical firm based in Hyderabad, reported third-quarter figures for 2025 on Friday, 9th May. Its net earnings increased 22% over the last ...

WASHINGTON, DC (IANS) – Drug makers Dr Reddy’s Laboratories, Sun Pharma and Aurobindo Pharma are recalling their products in the US due to manufacturing issues. According to the latest ...

Dr Reddy’s Laboratories is yet to report its Q4 FY25 earnings as schedule for May 9. Analysts are expecting to see subtle margin improvement on a quarterly basis, with price erosion in the US ...